| Rescue of altered HDAC activity recovers behavioural abnormalities in a mouse model of Angelman syndrome I Jamal, V Kumar, N Vatsa, S Shekhar, BK Singh, A Sharma, NR Jana Neurobiology of Disease 105, 99-108, 2017 | 28 | 2017 |
| Deficiency of Ube3a in Huntington's disease mice brain increases aggregate load and accelerates disease pathology M Maheshwari, S Shekhar, BK Singh, I Jamal, N Vatsa, V Kumar, ... Human molecular genetics 23 (23), 6235-6245, 2014 | 26 | 2014 |
| Inhibition of dual leucine zipper kinase prevents chemotherapy-induced peripheral neuropathy and cognitive impairments J Ma, S Goodwani, PJ Acton, V Buggia-Prevot, SR Kesler, I Jamal, ... Pain 162 (10), 2599-2612, 2021 | 17 | 2021 |
| Environmental enrichment improves behavioral abnormalities in a mouse model of Angelman syndrome I Jamal, V Kumar, N Vatsa, BK Singh, S Shekhar, A Sharma, NR Jana Molecular neurobiology 54, 5319-5326, 2017 | 15 | 2017 |
| Topoisomerase 1 inhibitor topotecan delays the disease progression in a mouse model of Huntington’s disease S Shekhar, N Vatsa, V Kumar, BK Singh, I Jamal, A Sharma, NR Jana Human molecular genetics 26 (2), 420-429, 2017 | 9 | 2017 |
| Sulforaphane prevents the reactivation of HIV-1 by suppressing NFκB signaling I Jamal, A Paudel, L Thompson, M Abdelmalek, IA Khan, VB Singh Journal of Virus Eradication 9 (3), 100341, 2023 | 4 | 2023 |
| Topotecan, a Topoisomerase-1 Inhibitor, Retards the Disease Pathogenesis in a Mouse Model of Huntington's Disease SS Kumar, N Vatsa, V Kumar, BK Singh, I Jamal, A Sharma, NR Jana NEUROTHERAPEUTICS 15 (1), 252-252, 2018 | | 2018 |
| Effect of Environmental Enrichment and Histone Deacetylase Inhibitors on Mouse Model of Angelman syndrome I Jamal Gurugram, 0 | | |
